These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33770244)

  • 1. Development of mouse monoclonal antibody for detecting hemagglutinin of avian influenza A(H7N9) virus and preventing virus infection.
    Chiang YW; Li CJ; Su HY; Hsieh KT; Weng CW; Chen HW; Chang SC
    Appl Microbiol Biotechnol; 2021 Apr; 105(8):3235-3248. PubMed ID: 33770244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and biochemical characterization of the monoclonal antibodies for specific detection of the emerging H5N8 and H5Nx avian influenza virus hemagglutinins.
    Cheng YC; Chang SC
    Appl Microbiol Biotechnol; 2021 Jan; 105(1):235-245. PubMed ID: 33245391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of rapid immunochromatographic test for hemagglutinin antigen of H7 subtype in patients infected with novel avian influenza A (H7N9) virus.
    Kang K; Chen L; Zhao X; Qin C; Zhan Z; Wang J; Li W; Dzakah EE; Huang W; Shu Y; Jiang T; Cao W; Xie M; Luo X; Tang S
    PLoS One; 2014; 9(3):e92306. PubMed ID: 24647358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and optimized pairing of mouse monoclonal antibodies for detecting hemagglutinin in novel H7 subtype influenza viruses.
    Wang H; Zhou J; Wang D; Huang B; Tan W
    Sci China Life Sci; 2020 Feb; 63(2):279-289. PubMed ID: 31147904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9.
    Li J; Zhang L; Bao L; Wang Y; Qiu L; Hu J; Tang R; Yu H; Shan J; Li Y; Qin C; Zhu F
    Chin Med J (Engl); 2022 Apr; 135(7):799-805. PubMed ID: 35671181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of a monoclonal antibody against the hemagglutinin stem of H7N9 subtype avian influenza virus].
    Zhao J; Zhu Y; Hu J; Hu Z; Liu X
    Sheng Wu Gong Cheng Xue Bao; 2022 Jan; 38(1):160-173. PubMed ID: 35142127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and Characterization of Monoclonal Antibodies Specific to Avian Influenza H5N1 Hemagglutinin Protein.
    Malik A; Mallajosyula VV; Mishra NN; Varadarajan R; Gupta SK
    Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):436-41. PubMed ID: 26683184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.
    Shen W; Wang Q; Wang Z; Liu M; Du Y; Yuan L; Han L; Smietanka K; Chen H; Xu S; Zhu Q
    J Virol; 2022 Sep; 96(18):e0123822. PubMed ID: 36037479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of H7N9 hemagglutinin novel protein epitopes that elicit strong antibody-dependent, cell-mediated cytotoxic activities with protection from influenza infection in mouse model.
    Zhu P; Yi X; Zhang L; Liu Y; Wang S; Gu J; Zhu X; Yu X
    Cell Immunol; 2021 Jan; 359():104255. PubMed ID: 33316647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach.
    Sun Z; Wang Q; Li G; Li J; Chen S; Qin T; Ma H; Peng D; Liu X
    Microbiol Spectr; 2021 Oct; 9(2):e0068721. PubMed ID: 34585985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus.
    Hu Z; Zhao J; Shi L; Hu J; Hu S; Liu X
    Virus Res; 2021 Jun; 298():198409. PubMed ID: 33819520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
    Zhang L; Jia N; Li J; Han Y; Cao W; Wang S; Huang Z; Lu S
    Hum Vaccin Immunother; 2014; 10(7):1949-58. PubMed ID: 25424804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anamnestic broadly reactive antibodies induced by H7N9 virus more efficiently bind to seasonal H3N2 strains.
    Chen Y; Hilchey SP; Wang J; Garigen J; Zand MS; Huang J
    Hum Vaccin Immunother; 2022 Nov; 18(6):2128014. PubMed ID: 36197079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of antibody response to an epitope spanning the haemagglutinin cleavage site of H7N9 subtype avian influenza virus for the differentiation of infected and vaccinated chickens.
    Hu Z; Zhang Y; Hu J; Hu S; Liu X
    Avian Pathol; 2022 Aug; 51(4):330-338. PubMed ID: 35297704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterisation of monoclonal antibodies specific to avian influenza H7N9 haemagglutinin protein.
    Malik A; Mallajosyula V; Mishra NN; Arukha AP; Varadarajan R; Gupta SK
    Indian J Med Microbiol; 2016; 34(4):489-494. PubMed ID: 27934828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice.
    Xu L; Bao L; Lau SY; Wu WL; Yuan J; Gu S; Li F; Lv Q; Xu Y; Pushko P; Chen H; Qin C
    Vaccine; 2016 May; 34(23):2627-33. PubMed ID: 27083426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus.
    Chang P; Lukosaityte D; Sealy JE; Rijal P; Sadeyen JR; Bhat S; Crossley S; Daines R; Huang KA; Townsend AR; Iqbal M
    J Virol; 2023 Jan; 97(1):e0143122. PubMed ID: 36541801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.
    Prabakaran M; Kumar SR; Raj KV; Wu X; He F; Zhou J; Kwang J
    Antiviral Res; 2014 Sep; 109():149-59. PubMed ID: 24997413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein.
    Jegaskanda S; Co MDT; Cruz J; Subbarao K; Ennis FA; Terajima M
    J Infect Dis; 2017 Mar; 215(5):818-823. PubMed ID: 28011910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.